Vimarsana
Biggest News Aggregation in the World

Page 8 - Medication Guide News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medication Guide. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medication Guide Today - Breaking & Trending Today

FDA: Safety Label Changes Required for BCMA-, CD19-Directed CAR T-Cell Therapies - Vimarsana News

FDA: Safety Label Changes Required for BCMA-, CD19-Directed CAR T-Cell Therapies

The FDA is requiring new safety information be included in the labeling for all BCMA- or CD19-directed autologous CAR T-cell immunotherapies.

FDA warns of secondary cancer risk tied to CAR-T therapies that treat cancer - Vimarsana News

FDA warns of secondary cancer risk tied to CAR-T therapies that treat cancer

The US Food and Drug Administration has issued a new warning about the possible risk of secondary cancers in cancer patients who have been treated with a form of immunotherapy

Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open - Vimarsana News

Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that the peer-reviewed Journal of Hand Surgery Global Open published Collagenase...

FDA warns of secondary cancer risk tied to CAR-T therapies that treat cancer - Vimarsana News

FDA warns of secondary cancer risk tied to CAR-T therapies that treat cancer

CBS 58 is your local source for the Milwaukee news, Milwaukee weather, and Milwaukee sports.

Source: cbs58.com
Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in Patients with Locally Advanced or Metastatic Urothelial Carcinoma - Vimarsana News

Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

ROCKLAND, Mass.--(BUSINESS WIRE)--Jan 22, 2024--